Impact of Tranexamic Acid on Red Blood Cell Transfusion in Spinal Surgery

• Status: Completed
• Trial end date: 2014-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Spinal surgery may be associated with substantial blood loss which often requires erythrocyte transfusion. Transfusion of red blood cells (RBC) is not free of adverse events and has been associated with increased risks of infection, and globally higher morbidity and mortality.

Different techniques have been used to reduce perioperative blood losses and related transfusions. Tranexamic acid has been used successfully in cardiac and hepatic surgery. However, only a few studies have reported on the use of antifibrinolytic drugs in spinal surgery.

This study was designed to assess the efficacy and safety of tranexamic acid in spinal surgery for the reduction of RBC transfusion.

Hypothesis: the infusion of tranexamic acid during spinal surgery will reduce the risk of receiving a RBC transfusion and, in those patients transfused, reduce the number of blood products administered.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
• Treatments: Tranexamic Acid

Criteria

Inclusion Criteria:

• Patients aged 18 to 85 years

• Patients undergoing spinal surgery with expected significant blood loss

• American Society of Anesthesiologists physical status(ASA) I to III inclusive

Exclusion Criteria:

• Allergy to tranexamic acid

• Epilepsy

• Minimally invasive surgery

• Unwillingness to receive blood transfusion

• Known coagulopathy/hepatic disease

• Previous thromboembolic events

• Pregnancy

• Renal impairment